Talimogene laherparepvec [electronic resource] : first-in-class oncolytic immunotherapy / Kevin Harrington.
Material type:![Film](/opac-tmpl/lib/famfamfam/VM.png)
Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Causing tumour cell lysis -- Initiating a specific systemic immune response -- T-VEC as an oncolytic HSV-1 strain -- Assessing cancer immunotherapy through melanoma -- Applicability of oncolytic viral therapy to various cancers.
Access restricted to subscribers.
Mode of access: World Wide Web.